Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA

Size: px
Start display at page:

Download "Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA"

Transcription

1 Pharmacophore Model Development for the Identification of Novel Acetylcholinesterase Inhibitors Edwin Kamau Dept Chem & Biochem Kennesa State Uni ersit Kennesa GA Dept. Chem. & Biochem. Kennesaw State University, Kennesaw, GA, Bioengineering & Bioinformatics Summer Institute, Dept. Computational Biology, University of Pittsburgh, PGH, PA

2 Background Acetylcholinesterase Acetylcholinesterase(AChE) is a multifunctional enzyme found in cholinergic system Function: Terminates nerve impulses of acetylcholine origin Promotes production of β-amyloid protein Associated with pathogenesis of Alzheimer's Disease (AD) Impairs cholinergic system Reduced amount of acetylcholine Promote formation of Plaques Insoluble β-amyloid protein com

3 Alzheimer's Disease Age related chronic neurodegenerative dementia Affects 20 million people worldwide Develops in stages Early to advanced Available drugs only able to treat certain stage only Drugs have associated side effects Need for therapeuticti measures with ability to treatt all stages of AD with less or no side effects

4 Structure Model structure of Torpedo californica AChE (TcAChE) Peripheral Anionic Site (PAS) Trp 279 Catalytic Anionic Site (CAS) Trp 84 Lining of aromatic residues 54 X-ray structures with bound ligands Xu. et al. Induced fit or preexisting equilibrium dynamics? 2008,17:601-5

5 Inhibition Binding activity at CAS well understood while that of PAS still elusive PAS site associated with formation of plaques Treatment at all stages of AD ineffective due to drug inhibition only at the CAS site Inhibition at both sites is key to effective treatment Hence using available generated dual-inhibitors of TcAChE will generate more effective inhibitors

6 Aims of this Study Develop a molecule-derived pharmacophore model (MOE) using known PAS and CAS inhibitors Use pharmacophore p model to identify structurally diverse active compounds by virtual screening

7 Strategy (LBDD) Start (SBDD) TcAChE Training set Top 5 Hits Pharmacophore Model Development Experimental testing (TBD) Pharmacophore Model Validation Lipinski`s Rule of Five Criteria 3D Database screening Top 25 Hits

8 ACTIVE DUAL INHIBITORS

9 Training set

10 Pharmacophore Query Generation Training set: 6 compounds Features defined: Hydrogen-bond acceptor (ACC) Hydrogen-bond donor (DON) Hydrophobic (HYD) Aromatic (ARO) Conformer generation 4 kcal/mol l

11 Queries 3 Queries generated: Query Molecule(s) Tolerance Radius Features a ReF_Vol Donepezil 1.74 HYD ARO 3Vols Ref_No _Vol Donepezil 1.4 HYD ARO Consensus All training set molecules 1.4 HYD ACC DON ARO. a ACC,hydrogen-bond acceptor; DON, hydrogen-bond donor; HYD, hydrophobic, ARO, ring aromatic, Vols, excluded volumes

12 Reference Queries Reference query without excluded volumes generated using Donepezil the meshed spheres represent pharmacophoric features. TRP 279 TRP84 PHE330 Reference query with excluded volumes generated using Donepezil. The meshed spheres are the pharmacophore features (ARO, HYD). Solid spheres (red, blue and cyan colored) represents excluded volumes.

13 Consensus Query Bis5 tacrine Bis10 Hupyridone Aminoquinoline28 Bw284c51 Decamethonium Donepezil Fig 4: Flexible aligned training set showing defined features scheme used to generate the query Consensus query generated from flexible aligned training set. The spheres are the pharmacophore features (Aro, Acc, Hyd, Don) that novel pharmacophores were aligned. Molecules matching those features satisfied the query and were therefore hits

14 Validation TEST SET: 8 active compounds All 8 molecules satisfied the three queries

15 Database Preparation & Search (MOE) ZINC ~ 2.8 M total number of compounds ~ 900,000 lead-like compounds 27,491 compounds screened Created conformation database: 703,313 compounds

16 Database Search Results and Sorting Query Ref:Vol Ref:No Vol Consensus Number of hits Sort top Common hits 68 Selection based on lowest rmsd value ( Å) 25

17 Sorted Hits (cont.) Consensus compounds generated by all queries and their respective RMSD values.

18 Sorted Hits (2D Structures)

19 Virtual Screening Flexible Docking with Molegro Virtal Docker Full side-chain flexibility Cavity detection dynamically used during the docking process Improved scoring function hydrogen bond directionality taken into account Table 1: Accuracy of selected docking programs. A binding mode is regarded as correctly identified if the RMSD (to the native co-crystallized ligand) is less than 2.0Å. The dataset consists of the 77 complexes *Thomsen R, Christensen M H, J Med Chem 2006; 49:

20 Docking Results Top 5 ZINC compounds docked in the binding sites of TcAChE

21 Docking Results (cont.) E2020 (Donepezil) and ZINC from different view points. Visual of how well the zinc compounds aligned in the binding site similar to Donepezil

22 Conclusion Using a combination of ligand based and structure based drug design approaches we have identified structurally diverse dual inhibitor candidates for TcAChE Future Work Virtually screen the remaining lead-like like compounds of the ZINC database Prioritize hits for experimental testing (i.e. binding free energy; types of interactions in the active site)

23 Acknowledgements Dr Gabriela Mustata Dr Jeffry Madura BBSI Program NIH & NSF

24 References 1. Lin A. Overview of pharmacophore p Application in MOE. Chemica Computing group. /ph4.htmhtm 2. Irwin and Stoichet. J. Chem. (2005); 45(1): Info. 3. Molegro Virtual Docker. molegro.com 4. Xu Model. Xu. et al. induced fit or preexisting equilibrium dynamics? Protein Science (2008), 17: 601-5

ing equilibrium i Dynamics? simulations on AchE and Implications for Edwin Kamau Protein Science (2008). 17: /29/08

ing equilibrium i Dynamics? simulations on AchE and Implications for Edwin Kamau Protein Science (2008). 17: /29/08 Induced-fit d or Pre-existin ing equilibrium i Dynamics? Lessons from Protein Crystallography yand MD simulations on AchE and Implications for Structure-based Drug De esign Xu Y. et al. Protein Science

More information

Structural biology and drug design: An overview

Structural biology and drug design: An overview Structural biology and drug design: An overview livier Taboureau Assitant professor Chemoinformatics group-cbs-dtu otab@cbs.dtu.dk Drug discovery Drug and drug design A drug is a key molecule involved

More information

DOCKING TUTORIAL. A. The docking Workflow

DOCKING TUTORIAL. A. The docking Workflow 2 nd Strasbourg Summer School on Chemoinformatics VVF Obernai, France, 20-24 June 2010 E. Kellenberger DOCKING TUTORIAL A. The docking Workflow 1. Ligand preparation It consists in the standardization

More information

Using Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017

Using Phase for Pharmacophore Modelling. 5th European Life Science Bootcamp March, 2017 Using Phase for Pharmacophore Modelling 5th European Life Science Bootcamp March, 2017 Phase: Our Pharmacohore generation tool Significant improvements to Phase methods in 2016 New highly interactive interface

More information

Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner

Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner Table of Contents Creating a Pharmacophore Query from a Reference Molecule & Scaffold Hopping in CSD-CrossMiner Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Features

More information

Targeting protein-protein interactions: A hot topic in drug discovery

Targeting protein-protein interactions: A hot topic in drug discovery Michal Kamenicky; Maria Bräuer; Katrin Volk; Kamil Ödner; Christian Klein; Norbert Müller Targeting protein-protein interactions: A hot topic in drug discovery 104 Biomedizin Innovativ patientinnenfokussierte,

More information

Performing a Pharmacophore Search using CSD-CrossMiner

Performing a Pharmacophore Search using CSD-CrossMiner Table of Contents Introduction... 2 CSD-CrossMiner Terminology... 2 Overview of CSD-CrossMiner... 3 Searching with a Pharmacophore... 4 Performing a Pharmacophore Search using CSD-CrossMiner Version 2.0

More information

Receptor Based Drug Design (1)

Receptor Based Drug Design (1) Induced Fit Model For more than 100 years, the behaviour of enzymes had been explained by the "lock-and-key" mechanism developed by pioneering German chemist Emil Fischer. Fischer thought that the chemicals

More information

Introduction to Chemoinformatics and Drug Discovery

Introduction to Chemoinformatics and Drug Discovery Introduction to Chemoinformatics and Drug Discovery Irene Kouskoumvekaki Associate Professor February 15 th, 2013 The Chemical Space There are atoms and space. Everything else is opinion. Democritus (ca.

More information

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre

Dr. Sander B. Nabuurs. Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre Dr. Sander B. Nabuurs Computational Drug Discovery group Center for Molecular and Biomolecular Informatics Radboud University Medical Centre The road to new drugs. How to find new hits? High Throughput

More information

Goals. Structural Analysis of the EGR Family of Transcription Factors: Templates for Predicting Protein DNA Interactions

Goals. Structural Analysis of the EGR Family of Transcription Factors: Templates for Predicting Protein DNA Interactions Structural Analysis of the EGR Family of Transcription Factors: Templates for Predicting Protein DNA Interactions Jamie Duke 1,2 and Carlos Camacho 3 1 Bioengineering and Bioinformatics Summer Institute,

More information

Medicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design

Medicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design Medicinal Chemistry/ CHEM 458/658 Chapter 4- Computer-Aided Drug Design Bela Torok Department of Chemistry University of Massachusetts Boston Boston, MA 1 Computer Aided Drug Design - Introduction Development

More information

Ligand Scout Tutorials

Ligand Scout Tutorials Ligand Scout Tutorials Step : Creating a pharmacophore from a protein-ligand complex. Type ke6 in the upper right area of the screen and press the button Download *+. The protein will be downloaded and

More information

Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery

Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery 21 th /June/2018@CUGM Progress of Compound Library Design Using In-silico Approach for Collaborative Drug Discovery Kaz Ikeda, Ph.D. Keio University Self Introduction Keio University, Tokyo, Japan (Established

More information

Docking. GBCB 5874: Problem Solving in GBCB

Docking. GBCB 5874: Problem Solving in GBCB Docking Benzamidine Docking to Trypsin Relationship to Drug Design Ligand-based design QSAR Pharmacophore modeling Can be done without 3-D structure of protein Receptor/Structure-based design Molecular

More information

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME Iván Solt Solutions for Cheminformatics Drug Discovery Strategies for known targets High-Throughput Screening (HTS) Cells

More information

Journal of Molecular Graphics and Modelling

Journal of Molecular Graphics and Modelling Journal of Molecular Graphics and Modelling 38 (2012) 194 210 Contents lists available at SciVerse ScienceDirect Journal of Molecular Graphics and Modelling j ourna l ho me page: www.elsevier.com/locate/jmgm

More information

Different conformations of the drugs within the virtual library of FDA approved drugs will be generated.

Different conformations of the drugs within the virtual library of FDA approved drugs will be generated. Chapter 3 Molecular Modeling 3.1. Introduction In this study pharmacophore models will be created to screen a virtual library of FDA approved drugs for compounds that may inhibit MA-A and MA-B. The virtual

More information

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a

Retrieving hits through in silico screening and expert assessment M. N. Drwal a,b and R. Griffith a Retrieving hits through in silico screening and expert assessment M.. Drwal a,b and R. Griffith a a: School of Medical Sciences/Pharmacology, USW, Sydney, Australia b: Charité Berlin, Germany Abstract:

More information

Computational chemical biology to address non-traditional drug targets. John Karanicolas

Computational chemical biology to address non-traditional drug targets. John Karanicolas Computational chemical biology to address non-traditional drug targets John Karanicolas Our computational toolbox Structure-based approaches Ligand-based approaches Detailed MD simulations 2D fingerprints

More information

LigandScout. Automated Structure-Based Pharmacophore Model Generation. Gerhard Wolber* and Thierry Langer

LigandScout. Automated Structure-Based Pharmacophore Model Generation. Gerhard Wolber* and Thierry Langer LigandScout Automated Structure-Based Pharmacophore Model Generation Gerhard Wolber* and Thierry Langer * E-Mail: wolber@inteligand.com Pharmacophores from LigandScout Pharmacophores & the Protein Data

More information

CHAPTER-2. Drug discovery is a comprehensive approach wherein several disciplines

CHAPTER-2. Drug discovery is a comprehensive approach wherein several disciplines 36 CAPTER-2 Molecular Modeling Analog Based Studies Drug discovery is a comprehensive approach wherein several disciplines are used to design or discover the drugs. The R&D expenditure incurred to bring

More information

Identifying Interaction Hot Spots with SuperStar

Identifying Interaction Hot Spots with SuperStar Identifying Interaction Hot Spots with SuperStar Version 1.0 November 2017 Table of Contents Identifying Interaction Hot Spots with SuperStar... 2 Case Study... 3 Introduction... 3 Generate SuperStar Maps

More information

Biologically Relevant Molecular Comparisons. Mark Mackey

Biologically Relevant Molecular Comparisons. Mark Mackey Biologically Relevant Molecular Comparisons Mark Mackey Agenda > Cresset Technology > Cresset Products > FieldStere > FieldScreen > FieldAlign > FieldTemplater > Cresset and Knime About Cresset > Specialist

More information

Electronic Supplementary Information. A biologically relevant fluorescent probe to assess the binding of ceramide to the CERT transfer protein

Electronic Supplementary Information. A biologically relevant fluorescent probe to assess the binding of ceramide to the CERT transfer protein This journal is The Royal Society of Chemistry 20 Electronic Supplementary Information A biologically relevant fluorescent probe to assess the binding of ceramide to the CERT transfer protein Stéphanie

More information

Introduction. OntoChem

Introduction. OntoChem Introduction ntochem Providing drug discovery knowledge & small molecules... Supporting the task of medicinal chemistry Allows selecting best possible small molecule starting point From target to leads

More information

Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification

Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification Fragment Hotspot Maps: A CSD-derived Method for Hotspot identification Chris Radoux www.ccdc.cam.ac.uk radoux@ccdc.cam.ac.uk 1 Introduction Hotspots Strongly attractive to organic molecules Organic molecules

More information

Computational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007

Computational Chemistry in Drug Design. Xavier Fradera Barcelona, 17/4/2007 Computational Chemistry in Drug Design Xavier Fradera Barcelona, 17/4/2007 verview Introduction and background Drug Design Cycle Computational methods Chemoinformatics Ligand Based Methods Structure Based

More information

CHAPTER 3. Pharmacophore modelling studies:

CHAPTER 3. Pharmacophore modelling studies: CHAPTER 3 Pharmacophore modelling studies: 3.1 Introduction: According to Langer & Wolber (2004), the key goal of computer-aided molecular design methods in medicinal chemistry is to reduce the time and

More information

Plan. Day 2: Exercise on MHC molecules.

Plan. Day 2: Exercise on MHC molecules. Plan Day 1: What is Chemoinformatics and Drug Design? Methods and Algorithms used in Chemoinformatics including SVM. Cross validation and sequence encoding Example and exercise with herg potassium channel:

More information

Building a Homology Model of the Transmembrane Domain of the Human Glycine α-1 Receptor

Building a Homology Model of the Transmembrane Domain of the Human Glycine α-1 Receptor Building a Homology Model of the Transmembrane Domain of the Human Glycine α-1 Receptor Presented by Stephanie Lee Research Mentor: Dr. Rob Coalson Glycine Alpha 1 Receptor (GlyRa1) Member of the superfamily

More information

Advanced Medicinal Chemistry SLIDES B

Advanced Medicinal Chemistry SLIDES B Advanced Medicinal Chemistry Filippo Minutolo CFU 3 (21 hours) SLIDES B Drug likeness - ADME two contradictory physico-chemical parameters to balance: 1) aqueous solubility 2) lipid membrane permeability

More information

Laboratory Exercises. Molecular Docking of Enzyme Inhibitors* hs A COMPUTATIONAL TOOL FOR STRUCTURE-BASED DRUG DESIGN

Laboratory Exercises. Molecular Docking of Enzyme Inhibitors* hs A COMPUTATIONAL TOOL FOR STRUCTURE-BASED DRUG DESIGN Q 2010 by The International Union of Biochemistry and Molecular Biology BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION Vol. 38, No. 4, pp. 261 265, 2010 Laboratory Exercises Molecular Docking of Enzyme Inhibitors*

More information

The Schrödinger KNIME extensions

The Schrödinger KNIME extensions The Schrödinger KNIME extensions Computational Chemistry and Cheminformatics in a workflow environment Jean-Christophe Mozziconacci Volker Eyrich Topics What are the Schrödinger extensions? Workflow application

More information

Viewing and Analyzing Proteins, Ligands and their Complexes 2

Viewing and Analyzing Proteins, Ligands and their Complexes 2 2 Viewing and Analyzing Proteins, Ligands and their Complexes 2 Overview Viewing the accessible surface Analyzing the properties of proteins containing thousands of atoms is best accomplished by representing

More information

11. IN SILICO DOCKING ANALYSIS

11. IN SILICO DOCKING ANALYSIS 11. IN SILICO DOCKING ANALYSIS 11.1 Molecular docking studies of major active constituents of ethanolic extract of GP The major active constituents are identified from the ethanolic extract of Glycosmis

More information

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining

Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining Development of Pharmacophore Model for Indeno[1,2-b]indoles as Human Protein Kinase CK2 Inhibitors and Database Mining Samer Haidar 1, Zouhair Bouaziz 2, Christelle Marminon 2, Tiomo Laitinen 3, Anti Poso

More information

Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses

Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Dispensing Processes Profoundly Impact Biological, Computational and Statistical Analyses Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc,

More information

Structure-based maximal affinity model predicts small-molecule druggability

Structure-based maximal affinity model predicts small-molecule druggability Structure-based maximal affinity model predicts small-molecule druggability Alan Cheng alan.cheng@amgen.com IMA Workshop (Jan 17, 2008) Druggability prediction Introduction Affinity model Some results

More information

Plan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics.

Plan. Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics. Plan Lecture: What is Chemoinformatics and Drug Design? Description of Support Vector Machine (SVM) and its used in Chemoinformatics. Exercise: Example and exercise with herg potassium channel: Use of

More information

Data Quality Issues That Can Impact Drug Discovery

Data Quality Issues That Can Impact Drug Discovery Data Quality Issues That Can Impact Drug Discovery Sean Ekins 1, Joe Olechno 2 Antony J. Williams 3 1 Collaborations in Chemistry, Fuquay Varina, NC. 2 Labcyte Inc, Sunnyvale, CA. 3 Royal Society of Chemistry,

More information

Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface

Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites. J. Andrew Surface Using Bayesian Statistics to Predict Water Affinity and Behavior in Protein Binding Sites Introduction J. Andrew Surface Hampden-Sydney College / Virginia Commonwealth University In the past several decades

More information

The PhilOEsophy. There are only two fundamental molecular descriptors

The PhilOEsophy. There are only two fundamental molecular descriptors The PhilOEsophy There are only two fundamental molecular descriptors Where can we use shape? Virtual screening More effective than 2D Lead-hopping Shape analogues are not graph analogues Molecular alignment

More information

Ping-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University.

Ping-Chiang Lyu. Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University. Pharmacophore-based Drug design Ping-Chiang Lyu Institute of Bioinformatics and Structural Biology, Department of Life Science, National Tsing Hua University 96/08/07 Outline Part I: Analysis The analytical

More information

Virtual screening in drug discovery

Virtual screening in drug discovery Virtual screening in drug discovery Pavel Polishchuk Institute of Molecular and Translational Medicine Palacky University pavlo.polishchuk@upol.cz Drug development workflow Vistoli G., et al., Drug Discovery

More information

Using AutoDock for Virtual Screening

Using AutoDock for Virtual Screening Using AutoDock for Virtual Screening CUHK Croucher ASI Workshop 2011 Stefano Forli, PhD Prof. Arthur J. Olson, Ph.D Molecular Graphics Lab Screening and Virtual Screening The ultimate tool for identifying

More information

Schrodinger ebootcamp #3, Summer EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist

Schrodinger ebootcamp #3, Summer EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist Schrodinger ebootcamp #3, Summer 2016 EXPLORING METHODS FOR CONFORMER SEARCHING Jas Bhachoo, Senior Applications Scientist Numerous applications Generating conformations MM Agenda http://www.schrodinger.com/macromodel

More information

Ligand-receptor interactions

Ligand-receptor interactions University of Silesia, Katowice, Poland 11 22 March 2013 Ligand-receptor interactions Dr. Pavel Polishchuk A.V. Bogatsky Physico-Chemical Institute of National Academy of Sciences of Ukraine Odessa, Ukraine

More information

Other Cells. Hormones. Viruses. Toxins. Cell. Bacteria

Other Cells. Hormones. Viruses. Toxins. Cell. Bacteria Other Cells Hormones Viruses Toxins Cell Bacteria ΔH < 0 reaction is exothermic, tells us nothing about the spontaneity of the reaction Δ H > 0 reaction is endothermic, tells us nothing about the spontaneity

More information

MM-PBSA Validation Study. Trent E. Balius Department of Applied Mathematics and Statistics AMS

MM-PBSA Validation Study. Trent E. Balius Department of Applied Mathematics and Statistics AMS MM-PBSA Validation Study Trent. Balius Department of Applied Mathematics and Statistics AMS 535 11-26-2008 Overview MM-PBSA Introduction MD ensembles one snap-shots relaxed structures nrichment Computational

More information

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller Chemogenomic: Approaches to Rational Drug Design Jonas Skjødt Møller Chemogenomic Chemistry Biology Chemical biology Medical chemistry Chemical genetics Chemoinformatics Bioinformatics Chemoproteomics

More information

Scoring functions for of protein-ligand docking: New routes towards old goals

Scoring functions for of protein-ligand docking: New routes towards old goals 3nd Strasbourg Summer School on Chemoinformatics Strasbourg, June 25-29, 2012 Scoring functions for of protein-ligand docking: New routes towards old goals Christoph Sotriffer Institute of Pharmacy and

More information

Hydrogen Bonding & Molecular Design Peter

Hydrogen Bonding & Molecular Design Peter Hydrogen Bonding & Molecular Design Peter Kenny(pwk.pub.2008@gmail.com) Hydrogen Bonding in Drug Discovery & Development Interactions between drug and water molecules (Solubility, distribution, permeability,

More information

Binding Response: A Descriptor for Selecting Ligand Binding Site on Protein Surfaces

Binding Response: A Descriptor for Selecting Ligand Binding Site on Protein Surfaces J. Chem. Inf. Model. 2007, 47, 2303-2315 2303 Binding Response: A Descriptor for Selecting Ligand Binding Site on Protein Surfaces Shijun Zhong and Alexander D. MacKerell, Jr.* Computer-Aided Drug Design

More information

Virtual Screening: How Are We Doing?

Virtual Screening: How Are We Doing? Virtual Screening: How Are We Doing? Mark E. Snow, James Dunbar, Lakshmi Narasimhan, Jack A. Bikker, Dan Ortwine, Christopher Whitehead, Yiannis Kaznessis, Dave Moreland, Christine Humblet Pfizer Global

More information

Supplementary information for cloud computing approaches for prediction of ligand binding poses and pathways

Supplementary information for cloud computing approaches for prediction of ligand binding poses and pathways Supplementary information for cloud computing approaches for prediction of ligand binding poses and pathways Morgan Lawrenz 1, Diwakar Shukla 1,2 & Vijay S. Pande 1,2 1 Department of Chemistry, Stanford

More information

Solutions and Non-Covalent Binding Forces

Solutions and Non-Covalent Binding Forces Chapter 3 Solutions and Non-Covalent Binding Forces 3.1 Solvent and solution properties Molecules stick together using the following forces: dipole-dipole, dipole-induced dipole, hydrogen bond, van der

More information

A Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors

A Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors A Tiered Screen Protocol for the Discovery of Structurally Diverse HIV Integrase Inhibitors Rajarshi Guha, Debojyoti Dutta, Ting Chen and David J. Wild School of Informatics Indiana University and Dept.

More information

High Throughput In-Silico Screening Against Flexible Protein Receptors

High Throughput In-Silico Screening Against Flexible Protein Receptors John von Neumann Institute for Computing High Throughput In-Silico Screening Against Flexible Protein Receptors H. Sánchez, B. Fischer, H. Merlitz, W. Wenzel published in From Computational Biophysics

More information

Supplementary Information

Supplementary Information Supplementary Information Resveratrol Serves as a Protein-Substrate Interaction Stabilizer in Human SIRT1 Activation Xuben Hou,, David Rooklin, Hao Fang *,,, Yingkai Zhang Department of Medicinal Chemistry

More information

Using Self-Organizing maps to accelerate similarity search

Using Self-Organizing maps to accelerate similarity search YOU LOGO Using Self-Organizing maps to accelerate similarity search Fanny Bonachera, Gilles Marcou, Natalia Kireeva, Alexandre Varnek, Dragos Horvath Laboratoire d Infochimie, UM 7177. 1, rue Blaise Pascal,

More information

Sequence Based Bioinformatics

Sequence Based Bioinformatics Structural and Functional Analysis of Inosine Monophosphate Dehydrogenase using Sequence-Based Bioinformatics Barry Sexton 1,2 and Troy Wymore 3 1 Bioengineering and Bioinformatics Summer Institute, Department

More information

Hit Finding and Optimization Using BLAZE & FORGE

Hit Finding and Optimization Using BLAZE & FORGE Hit Finding and Optimization Using BLAZE & FORGE Kevin Cusack,* Maria Argiriadi, Eric Breinlinger, Jeremy Edmunds, Michael Hoemann, Michael Friedman, Sami Osman, Raymond Huntley, Thomas Vargo AbbVie, Immunology

More information

Prediction and refinement of NMR structures from sparse experimental data

Prediction and refinement of NMR structures from sparse experimental data Prediction and refinement of NMR structures from sparse experimental data Jeff Skolnick Director Center for the Study of Systems Biology School of Biology Georgia Institute of Technology Overview of talk

More information

Similarity Search. Uwe Koch

Similarity Search. Uwe Koch Similarity Search Uwe Koch Similarity Search The similar property principle: strurally similar molecules tend to have similar properties. However, structure property discontinuities occur frequently. Relevance

More information

In silico pharmacology for drug discovery

In silico pharmacology for drug discovery In silico pharmacology for drug discovery In silico drug design In silico methods can contribute to drug targets identification through application of bionformatics tools. Currently, the application of

More information

Journal of Pharmacology and Experimental Therapy-JPET#172536

Journal of Pharmacology and Experimental Therapy-JPET#172536 A NEW NON-PEPTIDIC INHIBITOR OF THE 14-3-3 DOCKING SITE INDUCES APOPTOTIC CELL DEATH IN CHRONIC MYELOID LEUKEMIA SENSITIVE OR RESISTANT TO IMATINIB Manuela Mancini, Valentina Corradi, Sara Petta, Enza

More information

October 6 University Faculty of pharmacy Computer Aided Drug Design Unit

October 6 University Faculty of pharmacy Computer Aided Drug Design Unit October 6 University Faculty of pharmacy Computer Aided Drug Design Unit CADD@O6U.edu.eg CADD Computer-Aided Drug Design Unit The development of new drugs is no longer a process of trial and error or strokes

More information

GC and CELPP: Workflows and Insights

GC and CELPP: Workflows and Insights GC and CELPP: Workflows and Insights Xianjin Xu, Zhiwei Ma, Rui Duan, Xiaoqin Zou Dalton Cardiovascular Research Center, Department of Physics and Astronomy, Department of Biochemistry, & Informatics Institute

More information

Nature Structural and Molecular Biology: doi: /nsmb.2938

Nature Structural and Molecular Biology: doi: /nsmb.2938 Supplementary Figure 1 Characterization of designed leucine-rich-repeat proteins. (a) Water-mediate hydrogen-bond network is frequently visible in the convex region of LRR crystal structures. Examples

More information

Computational analysis of the activity of pongachalcone I against highly resistant bacteria Pseudomonas putida

Computational analysis of the activity of pongachalcone I against highly resistant bacteria Pseudomonas putida Computational analysis of the activity of pongachalcone I against highly resistant bacteria Pseudomonas putida Satya B. Paul 1, Sudip Choudhury 2,* 1 Department of Chemistry, Assam University, Silchar,

More information

Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design

Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design Molecular Dynamics Simulation Study and Hybrid Pharmacophore Model Development in Human LTA4H Inhibitor Design Sundarapandian Thangapandian, Shalini John, Mahreen Arooj, Keun Woo Lee* Division of Applied

More information

What is Protein-Ligand Docking?

What is Protein-Ligand Docking? MOLECULAR DOCKING Definition: What is Protein-Ligand Docking? Computationally predict the structures of protein-ligand complexes from their conformations and orientations. The orientation that maximizes

More information

International Journal of Integrative Biology A journal for biology beyond borders ISSN

International Journal of Integrative Biology A journal for biology beyond borders ISSN Report International Journal of Integrative Biology A journal for biology beyond borders ISSN 0973-8363 against acetylcholine esterase associated with Alzheimer s disease Sriramamurthy Boppana 1, Nataraj

More information

Structure based drug design and LIE models for GPCRs

Structure based drug design and LIE models for GPCRs Structure based drug design and LIE models for GPCRs Peter Kolb kolb@docking.org Shoichet Lab ACS 237 th National Meeting, March 24, 2009 p.1/26 [Acknowledgements] Brian Shoichet John Irwin Mike Keiser

More information

Structure Investigation of Fam20C, a Golgi Casein Kinase

Structure Investigation of Fam20C, a Golgi Casein Kinase Structure Investigation of Fam20C, a Golgi Casein Kinase Sharon Grubner National Taiwan University, Dr. Jung-Hsin Lin University of California San Diego, Dr. Rommie Amaro Abstract This research project

More information

*Corresponding Author *K. F.: *T. H.:

*Corresponding Author *K. F.:   *T. H.: Theoretical Analysis of Activity Cliffs among Benzofuranone Class Pim1 Inhibitors Using the Fragment Molecular Orbital Method with Molecular Mechanics Poisson-Boltzmann Surface Area (FMO+MM-PBSA) Approach

More information

Protein Structure Prediction and Protein-Ligand Docking

Protein Structure Prediction and Protein-Ligand Docking Protein Structure Prediction and Protein-Ligand Docking Björn Wallner bjornw@ifm.liu.se Jan. 24, 2014 Todays topics Protein Folding Intro Protein structure prediction How can we predict the structure of

More information

5.1. Hardwares, Softwares and Web server used in Molecular modeling

5.1. Hardwares, Softwares and Web server used in Molecular modeling 5. EXPERIMENTAL The tools, techniques and procedures/methods used for carrying out research work reported in this thesis have been described as follows: 5.1. Hardwares, Softwares and Web server used in

More information

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences

György M. Keserű H2020 FRAGNET Network Hungarian Academy of Sciences Fragment based lead discovery - introduction György M. Keserű H2020 FRAGET etwork Hungarian Academy of Sciences www.fragnet.eu Hit discovery from screening Druglike library Fragment library Large molecules

More information

Kd = koff/kon = [R][L]/[RL]

Kd = koff/kon = [R][L]/[RL] Taller de docking y cribado virtual: Uso de herramientas computacionales en el diseño de fármacos Docking program GLIDE El programa de docking GLIDE Sonsoles Martín-Santamaría Shrödinger is a scientific

More information

Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson s Disease-Linked LRRK2 Mutant G2019S.

Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson s Disease-Linked LRRK2 Mutant G2019S. Type II Kinase Inhibitors Show an Unexpected Inhibition Mode against Parkinson s Disease-Linked LRRK2 Mutant G219S. Min Liu@&*, Samantha A. Bender%*, Gregory D Cuny@, Woody Sherman, Marcie Glicksman@ Soumya

More information

Generating Small Molecule Conformations from Structural Data

Generating Small Molecule Conformations from Structural Data Generating Small Molecule Conformations from Structural Data Jason Cole cole@ccdc.cam.ac.uk Cambridge Crystallographic Data Centre 1 The Cambridge Crystallographic Data Centre About us A not-for-profit,

More information

Design and Synthesis of the Comprehensive Fragment Library

Design and Synthesis of the Comprehensive Fragment Library YOUR INNOVATIVE CHEMISTRY PARTNER IN DRUG DISCOVERY Design and Synthesis of the Comprehensive Fragment Library A 3D Enabled Library for Medicinal Chemistry Discovery Warren S Wade 1, Kuei-Lin Chang 1,

More information

Drug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters

Drug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters Drug Design 2 Oliver Kohlbacher Winter 2009/2010 11. QSAR Part 4: Selected Chapters Abt. Simulation biologischer Systeme WSI/ZBIT, Eberhard-Karls-Universität Tübingen Overview GRIND GRid-INDependent Descriptors

More information

Protein Structure. W. M. Grogan, Ph.D. OBJECTIVES

Protein Structure. W. M. Grogan, Ph.D. OBJECTIVES Protein Structure W. M. Grogan, Ph.D. OBJECTIVES 1. Describe the structure and characteristic properties of typical proteins. 2. List and describe the four levels of structure found in proteins. 3. Relate

More information

ICM-Chemist-Pro How-To Guide. Version 3.6-1h Last Updated 12/29/2009

ICM-Chemist-Pro How-To Guide. Version 3.6-1h Last Updated 12/29/2009 ICM-Chemist-Pro How-To Guide Version 3.6-1h Last Updated 12/29/2009 ICM-Chemist-Pro ICM 3D LIGAND EDITOR: SETUP 1. Read in a ligand molecule or PDB file. How to setup the ligand in the ICM 3D Ligand Editor.

More information

Towards Physics-based Models for ADME/Tox. Tyler Day

Towards Physics-based Models for ADME/Tox. Tyler Day Towards Physics-based Models for ADME/Tox Tyler Day Overview Motivation Application: P450 Site of Metabolism Application: Membrane Permeability Future Directions and Applications Motivation Advantages

More information

BUDE. A General Purpose Molecular Docking Program Using OpenCL. Richard B Sessions

BUDE. A General Purpose Molecular Docking Program Using OpenCL. Richard B Sessions BUDE A General Purpose Molecular Docking Program Using OpenCL Richard B Sessions 1 The molecular docking problem receptor ligand Proteins typically O(1000) atoms Ligands typically O(100) atoms predicted

More information

Enhancing Specificity in the Janus Kinases: A Study on the Thienopyridine. JAK2 Selective Mechanism Combined Molecular Dynamics Simulation

Enhancing Specificity in the Janus Kinases: A Study on the Thienopyridine. JAK2 Selective Mechanism Combined Molecular Dynamics Simulation Electronic Supplementary Material (ESI) for Molecular BioSystems. This journal is The Royal Society of Chemistry 2015 Supporting Information Enhancing Specificity in the Janus Kinases: A Study on the Thienopyridine

More information

Joana Pereira Lamzin Group EMBL Hamburg, Germany. Small molecules How to identify and build them (with ARP/wARP)

Joana Pereira Lamzin Group EMBL Hamburg, Germany. Small molecules How to identify and build them (with ARP/wARP) Joana Pereira Lamzin Group EMBL Hamburg, Germany Small molecules How to identify and build them (with ARP/wARP) The task at hand To find ligand density and build it! Fitting a ligand We have: electron

More information

Supporting Information

Supporting Information Supporting Information Ottmann et al. 10.1073/pnas.0907587106 Fig. S1. Primary structure alignment of SBT3 with C5 peptidase from Streptococcus pyogenes. The Matchmaker tool in UCSF Chimera (http:// www.cgl.ucsf.edu/chimera)

More information

SUPPLEMENTARY INFORMATION

SUPPLEMENTARY INFORMATION doi:10.1038/nature17991 Supplementary Discussion Structural comparison with E. coli EmrE The DMT superfamily includes a wide variety of transporters with 4-10 TM segments 1. Since the subfamilies of the

More information

Structure to Function. Molecular Bioinformatics, X3, 2006

Structure to Function. Molecular Bioinformatics, X3, 2006 Structure to Function Molecular Bioinformatics, X3, 2006 Structural GeNOMICS Structural Genomics project aims at determination of 3D structures of all proteins: - organize known proteins into families

More information

Introduction to Structure Preparation and Visualization

Introduction to Structure Preparation and Visualization Introduction to Structure Preparation and Visualization Created with: Release 2018-4 Prerequisites: Release 2018-2 or higher Access to the internet Categories: Molecular Visualization, Structure-Based

More information

QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression

QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression APPLICATION NOTE QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression GAINING EFFICIENCY IN QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIPS ErbB1 kinase is the cell-surface receptor

More information

Ignasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015

Ignasi Belda, PhD CEO. HPC Advisory Council Spain Conference 2015 Ignasi Belda, PhD CEO HPC Advisory Council Spain Conference 2015 Business lines Molecular Modeling Services We carry out computational chemistry projects using our selfdeveloped and third party technologies

More information

Implementation of novel tools to facilitate fragment-based drug discovery by NMR:

Implementation of novel tools to facilitate fragment-based drug discovery by NMR: Implementation of novel tools to facilitate fragment-based drug discovery by NMR: Automated analysis of large sets of ligand-observed NMR binding data and 19 F methods Andreas Lingel Global Discovery Chemistry

More information

Lecture 2 and 3: Review of forces (ctd.) and elementary statistical mechanics. Contributions to protein stability

Lecture 2 and 3: Review of forces (ctd.) and elementary statistical mechanics. Contributions to protein stability Lecture 2 and 3: Review of forces (ctd.) and elementary statistical mechanics. Contributions to protein stability Part I. Review of forces Covalent bonds Non-covalent Interactions: Van der Waals Interactions

More information

Preparation and Characterization of Manganese (II) Complexes with Potential Therapeutic Application against α-synuclein Aggregation

Preparation and Characterization of Manganese (II) Complexes with Potential Therapeutic Application against α-synuclein Aggregation Preparation and Characterization of Manganese (II) Complexes with Potential Therapeutic Application against α-synuclein Aggregation Kate Byrne BSc Medicinal Chemistry & Pharmaceutical Science Year 3 Project

More information